ENTRY       D10684                      Drug
NAME        Antithrombin gamma (INN);
            Antithrombin gamma (genetical recombination) (JAN);
            Acoalan (TN)
SEQUENCE    HGSPVDICTA KPRDIPMNPM CIYRSPEKKA TEDEGSEQKI PEATNRRVWE LSKANSRFAT
            TFYQHLADSK NDNDNIFLSP LSISTAFAMT KLGACNDTLQ QLMEVFKFDT ISEKTSDQIH
            FFFAKLNCRL YRKANKSSKL VSANRLFGDK SLTFNETYQD ISELVYGAKL QPLDFKENAE
            QSRAAINKWV SNKTEGRITD VIPSEAINEL TVLVLVNTIY FKGLWKSKFS PENTRKELFY
            KADGESCSAS MMYQEGKFRY RRVAEGTQVL ELPFKGDDIT MVLILPKPEK SLAKVEKELT
            PEVLQEWLDE LEEMMLVVHM PRFRIEDGFS LKEQLQDMGL VDLFSPEKSK LPGIVAEGRD
            DLYVSDAFHK AFLEVNEEGS EAAASTAVVI AGRSLNPNRV TFKANRPFLV FIREVPLNTI
            IFMGRVANPC VK
            (Disulfide bridge: 8-128, 21-95, 247-430)
  TYPE      Peptide
REMARK      Therapeutic category: 6349
            Product: D10684<JP>
EFFICACY    Antithrombotic
COMMENT     Recombinant antithrombin [HSA:462] [KO:K03911]
            See F2 [HSA:2147] [KO:K01313]
            See F10 [HSA:2159] [KO:K01314]
            See F12 [HSA:2161] [KO:K01328]
            See F9 [HSA:2158] [KO:K01321]
            See F11 [HSA:2160] [KO:K01323]
INTERACTION  
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              63  Biological preparations
               634  Human blood preparations
                6349  Others
                 D10684  Antithrombin gamma (INN); Antithrombin gamma (genetical recombination) (JAN)
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10684
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10684
DBLINKS     CAS: 1311281-25-0
            PubChem: 254741645
///
